Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.
Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from a single CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services.
Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.
ExplORer Surgical is an interactive surgical playbook that reduces disruptions and wasted disposables by improving surgical team communication. ExplORer Surgical also provides real-time performance and scheduling data to OR administrators to enhance the quality of care and efficiency. Surgical teams use the software to coordinate their activities while managing their tools and supplies in a way never before possible. The result is optimal teamwork, increased efficiency, and high performance. ExplORer Surgical keeps high functioning teams in sync so that physicians can focus on what they do best performing successful procedures that help patients live their best lives. The Explorer provides workflow management through tailored checklists which reduce errors, track efficiency, and eliminate confusion among team members in the OR and procedural suites. It helps medical device companies ease rollout of new devices, saving time and money while improving medical education.
MIVI Neuroscience focuses on the development and commercialization of clinical solutions for neurointerventional procedures. Their innovative product portfolio provides physicians with unique devices that improve patient outcomes by reducing complications, shortening procedure times, and expanding treatment to more patients. The company was founded in 2013 and is headquartered in Eden Prairie, Minnesota.
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement, mobility, and personalized care that is unavailable with traditional compression therapy.
Orpyx Medical Technologies empowers people with diabetes to maintain mobility. The company’s core product line, the Orpyx SI sensory insoles with remote patient monitoring, helps manage and prevent diabetic foot ulcers and limb loss through advanced foot sensor technology and real-time analytics. Orpyx technology is also used by researchers to access clinical-grade plantar pressure data for health and human performance applications in the fields of sports medicine, therapeutic applications, and footwear design. Orpyx is focused on collaborating with stakeholders around the world to achieve a healthcare future that is prevention-focused and sustainable in cost. Orpyx Medical Technologies was founded in 2010 and is headquartered in Calgary, Alberta, Canada.
Zeto is a commercial stage medical technology startup transforming the way EEG (Electroencephalography) is done at hospitals. We are solving a problem unsolved since EEG was invented in 1924, i.e., an archaic, tedious approach that consumes time, requires a trained technician and puts the patient through a poor experience. Our product is the first FDA cleared wireless, zero-prep, easy-to-wear headset with dry electrodes. The device is backed by a digital platform that offers instant upload, tools for analysis, and remote interpretation by neurologists. A process that takes over 30 mins by a technician just to set up will instead take just 5 minutes from putting on the headset to interpretable EEG. Zeto has won several awards including $350,000 from the Epilepsy Foundation, 2018 MedTech Innovator Showcase company, 2018 Exponential Medicine MEDY Outstanding Pitch Award, 2017 Rosenman Innovator by UCSF's QB3.
ExplORer Surgical is an interactive surgical playbook that reduces disruptions and wasted disposables by improving surgical team communication. ExplORer Surgical also provides real-time performance and scheduling data to OR administrators to enhance the quality of care and efficiency. Surgical teams use the software to coordinate their activities while managing their tools and supplies in a way never before possible. The result is optimal teamwork, increased efficiency, and high performance. ExplORer Surgical keeps high functioning teams in sync so that physicians can focus on what they do best performing successful procedures that help patients live their best lives. The Explorer provides workflow management through tailored checklists which reduce errors, track efficiency, and eliminate confusion among team members in the OR and procedural suites. It helps medical device companies ease rollout of new devices, saving time and money while improving medical education.
Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device. The company has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. It is also designed to be comfortable for women to wear, with its narrow, hourglass shape. Bardy Diagnostics uses his expertise to develop cardiac monitoring solutions that help physicians obtain more accurate information about actionable events in the hopes of saving lives. The company's mission is to improve clinical management and outcomes for patients and their physicians by employing innovative P-wave centric ECG detection into patient-friendly technologies that result in greater patient compliance and more confident physician diagnoses. Bardy Diagnostics was founded in 2013 and is headquartered in Seattle, Washington, USA.
Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers, allowing diabetic patients to monitor their blood glucose levels.
Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to the $2 billion worldwide cervical spine market. The Providence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY® line of bone and facet screws. All products are shipped-sterile and single-use to maximize perioperative efficiency and ensure consistent quality and performance.
iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearing aid. iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR. iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers. iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies.
ExplORer Surgical is an interactive surgical playbook that reduces disruptions and wasted disposables by improving surgical team communication. ExplORer Surgical also provides real-time performance and scheduling data to OR administrators to enhance the quality of care and efficiency. Surgical teams use the software to coordinate their activities while managing their tools and supplies in a way never before possible. The result is optimal teamwork, increased efficiency, and high performance. ExplORer Surgical keeps high functioning teams in sync so that physicians can focus on what they do best performing successful procedures that help patients live their best lives. The Explorer provides workflow management through tailored checklists which reduce errors, track efficiency, and eliminate confusion among team members in the OR and procedural suites. It helps medical device companies ease rollout of new devices, saving time and money while improving medical education.
iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearing aid. iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR. iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers. iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies.
Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to the $2 billion worldwide cervical spine market. The Providence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY® line of bone and facet screws. All products are shipped-sterile and single-use to maximize perioperative efficiency and ensure consistent quality and performance.
iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearing aid. iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR. iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers. iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies.
Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to the $2 billion worldwide cervical spine market. The Providence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY® line of bone and facet screws. All products are shipped-sterile and single-use to maximize perioperative efficiency and ensure consistent quality and performance.
CyMedica Orthopedics develops and commercializes innovative products that target joint injuries and the resulting muscle atrophy. Its mission is to address this problem with proprietary neuromuscular electrical stimulation. Its platform technology utilizes closed-loop power control systems to provide patients with comfortable yet aggressive treatment.
iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearing aid. iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR. iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers. iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies.
Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions. The company has pioneered a proprietary approach to cervical fusion and has developed surgical instrumentation and implants that offer unique benefits to the $2 billion worldwide cervical spine market. The Providence family of products includes the DTRAX® Spinal Instrumentation System, CAVUX® intervertebral implants, and the ALLY® line of bone and facet screws. All products are shipped-sterile and single-use to maximize perioperative efficiency and ensure consistent quality and performance.
Mercator MedSystems’ mission is to become a global leader in interventional, site-specific delivery of therapeutics that improve patient outcomes in vascular disease, oncology, and regenerative medicine. The 15th and 16th Centuries marked the beginning of the Age of Exploration, a time of bold action, vast territorial expansion and profound intellectual discovery. Gerardus Mercator (1512-1594), a mathematician and cartographer, played a key role in these ventures. He was as important to navigation as Copernicus was to astronomy. He perfected a map projection that was the first to represent the spherical surface of the earth in two dimensions. The Mercator Projection effectively transformed navigation, making it possible for ships to deliver cargo safely to any port on the globe. Inspired by the spirit of our namesake, Mercator MedSystems has developed a medical technology that enables the safe and accurate delivery of therapies anywhere in the body, ranging from drugs for diseased blood vessels, to stem cells that regenerate ailing tissues and organs. We believe this breakthrough will allow the expansion of medical therapy and stimulate profound intellectual exploration into new treatments for disease. We invite you to explore our web site, our technology and products, and to follow our progress to a new world of therapeutic delivery.
VideoCare is a revolution in technology that keeps families and their aging loved ones better connected — wherever they are. VideoCare provides the elderly care recipient with a touch-screen system that requires no keyboard, mouse or technical skill to use. A simple touch opens a two-way video connection with a professional caregiver, family member or friend.
Surgiquest offers technology solutions for minimally invasive surgery. It offers AirSeal, a technology that creates an air curtain that maintains an insufflated and airtight environment and has application in laparoscopic and laparoscopic-assisted surgery. The company focuses on bariatric, colorectal, general, gynecological, and urologic surgery. Surgiquest was incorporated in 2006 and is based in Orange, Connecticut.
ClearFlow is a medical device company developing technologies to solve clinical problems associated with obstructed catheters. The company's platform of catheter systems enables caregivers to actively clear internal obstructions to ensure these critical tubes perform optimally. The company’s lead product, the PleuraFlow, Active Clearance Technology, (ACT) System, was developed by cardiothoracic surgeons to solve the problem of chest tube failure by clot obstruction allowing doctors to manage the bleeding and clogging in a safer fashion. By enabling improved postoperative blood evacuation, surgeons are able to utilize minimally invasive drainage tubes, decreasing the surgical footprint, and potentially increasing patient comfort. The company has a pipeline of products based on its proprietary tube clearance technologies to resolve catheter clogging in other medical market segments, including urinary catheters, gastrointestinal catheters, and wound drainage. It was founded in 2007 and headquartered in Irvine, California.
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.
Surgiquest offers technology solutions for minimally invasive surgery. It offers AirSeal, a technology that creates an air curtain that maintains an insufflated and airtight environment and has application in laparoscopic and laparoscopic-assisted surgery. The company focuses on bariatric, colorectal, general, gynecological, and urologic surgery. Surgiquest was incorporated in 2006 and is based in Orange, Connecticut.
iHEAR Medical is a California-based company dedicated to creating affordable high quality hearing solutions. While 95% of individuals with hearing loss could be successfully treated with hearing aids, only 14% currently use them due to persisting barriers, including high cost, limited access, and the stigma associated with wearing a visible hearing aid. iHEAR's proprietary FDA Cleared iHEARtest is the only at-home hearing screener available direct-to-consumer for self-assessment at-home. The iHEARtest is a tool for baseline hearing screening and annual screening as recommended for all diabetics and pre-diabetics due to the fact that the diabetic population is 20%-30% more likely to have a hearing loss than those with normal blood glucose. The iHEARtest is available online from iHEAR or at select retail pharmacies across the U.S. The iHEARtest results in a Hearing Number(TM) for each ear that indicates degree of hearing loss. The Hearing Number is then used to determine which iHEAR hearing aid solution will be most appropriate for the consumer's degree of hearing loss using proprietary software applications from iHEAR. iHEAR has over 50 patents submitted with 27 patents issued on the technology, applications and services it provides in its end-to-end closed business model. iHEAR Medical is founded by Adnan Shennib, who previously founded and led the development of major Silicon Valley medical device firms including InSound Medical which was acquired in 2010 by Sonova-Phonak. iHEAR Medical is Shennib’s latest venture dedicated to creating affordable and accessible hearing aid solutions for consumers. iHEAR Medical's Board of Directors is comprised of seasoned venture capitalists and advisors who have presided over numerous successful healthcare companies.
Ikanos develops robust, high performance semiconductor and software products. Their advanced communications processors, broadband DSL and other devices power access infrastructure and customer premises equipment for many of the world’s leading network equipment manufacturers and telecommunications service providers. With more than 330 million ports shipped to date, they are enabling the cost-effective delivery of triple- and quadruple-play services to and throughout homes and offices around the world.
OrthoScan is a privately held medical device company which was founded in 2002 with the intent to bring to market a state of the art mini c‑arm and to provide innovative product solutions in orthopaedic imaging. Their first entry in the imaging market is the mini c‑arm, which is used for fluoroscopic imaging of the extremities in orthopaedic surgery and for digital diagnostic imaging in the office. They have built on the original concept of the mini c‑arm and have expanded their focus to provide their customers with other innovative technologies in orthopaedic imaging.
Corium International is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. This self-funded product pipeline spans several therapeutic areas and is in various stages of development. Corium also has several partner-funded products with small, medium and large pharmaceutical companies in various stages of development, ranging from manufacturing to research and development.
StrataGent Life Sciences, Inc. is a specialty drug therapy company developing painless, non-invasive versions of therapies that would otherwise be injected. Its products are based on its proprietary microjet technology, which delivers large and small therapeutic molecules without a device penetrating into or through the skin. In May of 2004, StrataGent received a $2 million award from the Advanced Technology Program (ATP) at the National Institute of Standards and Technology to support the development of the StrataGent microjet technology.
VasoNova, Inc. manufactures and markets medical devices. It develops a self-guided PICC catheter. The company is based in Sunnyvale, California.
Insulet Corporation is a medical device company that develops, manufactures, and sells insulin delivery systems for individuals with insulin-dependent diabetes. The company's primary product, the Omnipod System, consists of a disposable, tubeless insulin infusion device that adheres to the body for up to three days, along with a wireless personal diabetes manager for monitoring and control. Insulet markets its products through independent distributors and pharmacy channels, as well as directly to patients in the United States, Canada, Europe, and the Middle East. Founded in 2000, Insulet is headquartered in Acton, Massachusetts, and aims to enhance the quality of life for people managing diabetes through innovative technology.
Ikanos develops robust, high performance semiconductor and software products. Their advanced communications processors, broadband DSL and other devices power access infrastructure and customer premises equipment for many of the world’s leading network equipment manufacturers and telecommunications service providers. With more than 330 million ports shipped to date, they are enabling the cost-effective delivery of triple- and quadruple-play services to and throughout homes and offices around the world.
Silicon Access Networks is a provider of an ultra-high performance chipsets for terabit routers and communication silicon to the networking and telecommunications market.